Tesamorelin
5 mg
Retatrutide
Price range: $79.00 through $229.00
Research Use Only – Not for Human Consumption
99.3% Purity
Subcutaneous Injection
Lyophilized Powder
Lots & Certificates
Each released lot has one certificate of analysis. Check the lot number printed on your vial against this list.
Lot Number
AP-RET20-260410
Valid
RP-HPLC purity
99.313%
Quantity
21.04 mg
Endotoxins
1.18 EU/vial
Date tested
2026-10-02
Date received
2026-09-25
Testing lab
Chromate Analytical Services
Product Information
This product is for Research Use Only (RUO)
For qualified laboratory personnel only. Not for human or animal use.
Retatrutide is a 39-residue research peptide associated with GLP-1, GIP, and glucagon receptor studies.
Retatrutide Specifications
| Property | Value |
| Name and synonyms | Retatrutide, LY3437943, LY-3437943, GLP-3, Triple-G, GGG triagonist |
| PubChem CID | 171390338 |
| CAS number | 2381089-83-2 |
| FDA UNII | NOP2Y096GV |
| Molecular formula | C221H342N46O68 |
| Molecular weight | 4731.4 g/mol |
| Peptide length | 39 amino acids |
| Compound class | Synthetic triple incretin receptor agonist |
| Primary targets | GLP-1R, GIPR, GCGR |
| Receptor potency (human EC50) | GIPR 0.0643 nM; GLP-1R 0.775 nM; GCGR 5.79 nM |
| Half-life | Approximately 6 days |
| Physical form | White to off-white lyophilised powder |
| Solubility | Bacteriostatic or sterile water; DMSO; PBS pH 7.2 |
| Developer | Eli Lilly and Company |
| Purity | Please see COA |
| Vial sizes | Retatrutide 10mg, Retatrutide 20mg, Retatrutide 30mg |
Batch documentation
Match the product, presentation, and lot number to its certificate. Reported identity, purity, and content apply to the tested sample; a different lot is not interchangeable evidence.
Research scope
For laboratory research by qualified personnel. Not supplied for human or veterinary use. Handling and storage should follow the applicable batch documents and laboratory procedures.
Related products
View All
This product is for Research Use Only (RUO)